Consistent with these findings, the impairment of IGF2BP1-RNA association by the small molecule BTYNB substantially interferes with the IGF2BP1-driven expression of pro-oncogenic factors in cancer cells and impairs the tumor growth in mouse models (Mahapatra et al., 2017; Müller et al., 2020). The gene discussed is IGF2BP1; the disease is neoplasm.